Lenalidomide cancer drug for myeloma, molecular model. Lenalidomide is a treatment for multiple myeloma, a cancer of antibody-producing plasma cells. The compound is an analogue of thalidomide, and has similar toxicity and teratogenic properties. It is also a very expensive drug, costing more than USD150, 000 per year in the US. | |
Lizenzart: | Lizenzpflichtig |
Credit: | Science Photo Library / GREG WILLIAMS |
Bildgröße: | 4240 px × 2473 px |
Modell-Rechte: | nicht erforderlich |
Eigentums-Rechte: | nicht erforderlich |
Restrictions: | - |